Freedom Four
Friday, November 20, 2026
A Friday Hodgepodge
1. "Medicare for All Is Wrong, Not Merely Too Expensive," by Jared Rhoades (The Center for Modern Health):
Medicare for All would replace private health insurance with a compulsory system. It does not merely simplify a fragmented system or expand "coverage" to more people. It seizes control over an enormous share of the resources that individuals earn, save, and invest. It makes people pay for strangers' medical expenses by force. And eventually it must decide what counts as healthcare and which innovations qualify.640 words/2 minutes
The consequences for people who work in medicine may be even worse. Physicians and other health professionals have their own lives, judgment, ambitions, and plans. A government monopoly care would dictate the terms on which people can deal with one another. The right ideal isn't the fantasy that everything will be taken care of, somehow. The right ideal is that these participants should be able to make decisions within a system of voluntary exchange, guided by professional standards and their own ideas about how they would like to pursue health. Medicare for All can't possibly leave these decisions to free choice; it would necessarily subject more and more of these decisions to political priorities and bureaucratic rules.
2. "Why Trump Can't Quit Stephen Miller's Immigration Playbook," by Agustina Vergara Cid (The Orange County Register):
Trump is inconsistent on immigration because he lacks a guiding principle -- he responds instead to impulses and polls (he admitted during the interview that immigration enforcement hurt him in the midterms). So he ends up being swayed by his advisors who do have a consistent principle, however despicable, chief among them Stephen Miller.830 words/3 minutes
Miller is the architect behind the most draconian immigration policies and enforcement in the Trump administration. He is driven by an ideology and knows how to use government tools to curtail immigration. Whatever precarious and unprincipled positive view Trump has of immigrants is driven out by Miller's guidance. Trump stands for little, and is therefore susceptible to advice from those who stand consistently for something, however un-American. Trump's attempt at sympathy for the "good people" cleaning hotel rooms is fleeting; Miller's nativism is a deeply held ideology.
3. "The Midterms Offer No Champion of Individual Rights, but I'm Voting for the First Time Anyway," by Agustina Vergara Cid (The Orange County Register):
Voting is an important part of our political system, but it doesn't automatically make a government legitimate. Protecting individual rights does. And voting is neither the only nor the most important tool at my disposal. As I've argued before, speaking up and exercising our freedoms, chiefly our First Amendment rights, is essential to preserving and restoring American founding principles.830 words/3 minutes
If no candidate stands for individual rights, it's because the idea has lost ground in our culture. It's my job, and that of everyone who shares this principle, to speak up for it, defend it and change minds. Changing the menu of candidates depends on the American people embracing and advocating for the right ideas that made this country free in the first place. And this is a right everyone on American soil has, not only citizens.
4. "The Real Evergreening Problem in Drug Patent Policy: I-MAK's Inaccurate and Unreliable Drug Patent Claims," by Adam Mossoff (The Hudson Institute):
If I-MAK's [the Initiative for Medicines, Access, and Knowledge --ed] evergreening of its inaccurate patent numbers and unreliable counting methods occurred only in academic discussions in the ivory tower, its claims could be safely ignored. But they do not. I-MAK's unreliable and inaccurate numbers and its "monopoly" rhetoric are actively pushed into the drug pricing policy debates in Washington, D.C., promoting real-world legislation and regulatory actions that seek to eliminate patent rights on new drugs and biologics, impose new regulatory burdens on the biopharmaceutical sector, and even sanction innovators.4800 words/16 minutes
The U.S. continues to be a leader in new healthcare innovations; almost two-thirds of all new medicines are invented in the U.S. This global leadership, and the innumerable lives that have been saved by these healthcare inventions, are threatened when the drug innovation ecosystem is undone by legislation or regulatory actions that are based on policy-based evidence-making.
-- CAV